Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

16.7%

1 terminated out of 6 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed with results

Key Signals

80% success

Data Visualizations

Phase Distribution

1Total

P 1 (1)

Trial Status

Completed4

Suspended1

Terminated1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT04031469Suspended

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

NCT05579444Terminated

Systems Biology of Gastrointestinal and Related Diseases

NCT02551289Completed

MAgnetic Resonance Imaging in COeliac Disease

NCT01893775Phase 1Completed

Antibody Treatment for Advanced Celiac Disease

NCT01862510Completed

Detection of Celiac Disease in Patients With Hypothyroidism

NCT01476995Completed

Prognostic Indicators as Provided by the EPIC ClearView

Showing all 6 trials

Celiac Sprue